StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report released on Thursday. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
NYSE:CO opened at $1.02 on Thursday. The firm has a 50-day moving average of $1.03 and a two-hundred day moving average of $1.29. The stock has a market cap of $123.98 million, a P/E ratio of 1.59 and a beta of 0.16. Global Cord Blood has a 1-year low of $2.03 and a 1-year high of $5.50.
Global Cord Blood Company Profile
Read More
- Five stocks we like better than Global Cord Blood
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Stocks to Buy While Others Stay on the Sidelines
- What Does a Stock Split Mean?
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.